Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Protalix BioTherapeutics Inc.
DescriptionInhaled recombinant human alpha-1 antitrypsin (AAT; A1AT; SERPINA1)
Molecular Target Alpha-1 antitrypsin (AAT) (A1AT) (SERPINA1)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationEmphysema
Indication DetailsTreat emphysema due to alpha 1-antitrypsin (AAT; A1AT; SERPINA1)-deficiency
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today